Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
07/17/2013 | CN103204851A Benzamide derivative containing fused heterocyclic group and therapeutic use thereof |
07/17/2013 | CN103204844A Amino heteroaryl compound, and preparation method and application thereof |
07/17/2013 | CN103204839A Synchronous preparation method of effective ingredient of licorice |
07/17/2013 | CN103204838A Synthesis of polyhydroxybenzo pyrone compound and antineoplastic effect of the compound |
07/17/2013 | CN103204827A Benzothiadiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
07/17/2013 | CN103204825A Benzothiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
07/17/2013 | CN103204824A 2-aminothiazole-4-amide derivative, its preparation method and application |
07/17/2013 | CN103204822A Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof |
07/17/2013 | CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof |
07/17/2013 | CN103204808A Biquinoline derivative, preparation method thereof and application thereof in preparing anticancer medicament |
07/17/2013 | CN103204781A 2, 7-bi-substituted fluorenone derivative and preparation method and application thereof |
07/17/2013 | CN103204771A Naphthoquinone or naphthalenone compounds and preparation methods thereof and applications of drugs thereof |
07/17/2013 | CN103203024A Targeting nano diamond carrier and targeted drug, and preparation method and application thereof |
07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
07/17/2013 | CN103202940A Antiphlogistic drug |
07/17/2013 | CN103202898A Traditional chinese medicine composition and preparation method thereof |
07/17/2013 | CN103202886A Traditional chinese medicine composition and preparation method thereof |
07/17/2013 | CN103202877A Application of total salvianolic acids in drugs for preventing cardiotoxicity induced by arsenic trioxide and tumor inhibition synergic drugs |
07/17/2013 | CN103202875A Application of Shen-Gui pills in preparation of drugs for tumor inhibition and combined chemotherapy drugs |
07/17/2013 | CN103202871A Externally-applied medicine patch for dehydration and detumescence, and production method of same |
07/17/2013 | CN103202869A Traditional chinese medicine composition and preparation method thereof |
07/17/2013 | CN103202861A Application of composition of clostridium butyricum and bifidobacterium dual live bacteria preparation and anticancer medicament in preparation of medicament for treating intestinal cancer |
07/17/2013 | CN103202856A Preparation method and application of medicine used for treating tumors |
07/17/2013 | CN103202850A Application of ginsenoside F4 in preparation of drug for treating lymphoma |
07/17/2013 | CN103202843A Application of pyrimidine derivative in preparation of drugs capable of prevention and/or treatment and/or adjuvant therapy of cancers |
07/17/2013 | CN103202842A Methods Of Treating By Inhibiting With Quinaxoline Inhibitors Of P13k-alpha |
07/17/2013 | CN103202837A Applications of artemisine derivatives and pharmaceutically acceptable salts thereof in preparing drugs for treating leukemia |
07/17/2013 | CN103202836A Applications of artemisine derivatives and pharmaceutically acceptable salts thereof in preparing drugs for treating acute myelocytic leukemia |
07/17/2013 | CN103202835A Applications of artemisine derivatives and pharmaceutically acceptable salts thereof in preparing drugs for treating acute leukemia |
07/17/2013 | CN103202834A Applications of oridonin in the preparation of antineoplastic drugs |
07/17/2013 | CN103202825A Application of curcumin analogue |
07/17/2013 | CN103202824A Application of pinitol to pharmacy and health care product |
07/17/2013 | CN103202813A Method for preparing protein nanoparticles for in vivo delivery of pharmacologically active substances |
07/17/2013 | CN103202812A Method for preparing protein nanoparticles for delivering pharmacological active substances inside human bodies |
07/17/2013 | CN103202810A Chinese actinidia root polysaccharide lipidosome and preparation method thereof |
07/17/2013 | CN103202808A Method for preparing multi-functional gossypol nano preparation by using one-pot method |
07/17/2013 | CN102872137B Application of Houttuynoid B in drug for treating cervical cancer |
07/17/2013 | CN102872135B Application of Houttuynoid D in drug for treating renal cancer |
07/17/2013 | CN102872129B Application of Houttuynoid E in drug for treating endometrial cancer |
07/17/2013 | CN102872118B Application of Houttuynoid D in medicament for preventing lung cancer metastasis |
07/17/2013 | CN102872117B Application of Houttuynoid D in preparing medicine for treating gastric cancer |
07/17/2013 | CN102872108B Application of Houttuynoid A in medicine for treating bile duct cancer |
07/17/2013 | CN102872100B Application of Houttuynoid B in medicine for treating lung cancer |
07/17/2013 | CN102872096B Application of Houttuynoid E in preparing medicine for treating lung cancer |
07/17/2013 | CN102872080B Application of Houttuynoid A in drugs for treating cervical cancer |
07/17/2013 | CN102872078B Application of Houttuynoid C in drugs for treating leukemia |
07/17/2013 | CN102861096B Application of Houttuynoid E in preparing medicine for treating cervical cancer |
07/17/2013 | CN102861091B Application of Houttuynoid C in anti-lung cancerometastasis medicine |
07/17/2013 | CN102861064B Application of Houttuynoid E in preparing medicine for treating laryngocarcinoma |
07/17/2013 | CN102776235B Recombinant expression plasmid and application thereof in preparing anti-tumor immunogene therapeutic medicament |
07/17/2013 | CN102614466B Traditional Chinese medical preparation for treatment of lung adenocarcinoma |
07/17/2013 | CN102580113B Method for producing cis-platinum supermolecule micelle prodrug |
07/17/2013 | CN102579916B Capsules for treating respiratory tract and digestive tract cancers and preparation method thereof |
07/17/2013 | CN102579896B Natural Chinese herbal medicine anticancer pill |
07/17/2013 | CN102499943B Preparation and anti-tumor activity of polymer wrapped heteropoly acid nano hybrid material |
07/17/2013 | CN102462668B Hydrochloric acid boningmycin solid preparation and preparation method thereof |
07/17/2013 | CN102441179B Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof |
07/17/2013 | CN102429895B Application of natural compound P48 in inhibition of tumor cell reproduction and growth |
07/17/2013 | CN102293959B Anticancer traditional Chinese medicine and preparation method thereof |
07/17/2013 | CN102276626B Isoxazole-containing compound |
07/17/2013 | CN102276625B 噻二唑衍生物 Thiadiazole derivatives |
07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
07/17/2013 | CN102174414B Application of new morchella costata M8-13 liquid fermentation substance in development of health-care products and medicaments |
07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
07/17/2013 | CN102146142B Method for preparing astragalus polysaccharides |
07/17/2013 | CN102106864B Application of icariin for preparing medicament for resisting myeloid-derived suppressor cells (MDSCs) |
07/17/2013 | CN102093340B Preparation method and application of 2-methylindazole derivatives |
07/17/2013 | CN101998951B Acylthiourea compound or salt thereof, and use thereof |
07/17/2013 | CN101985037B Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
07/17/2013 | CN101951910B Pharmaceutical use of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor KIT with imatinib |
07/17/2013 | CN101928329B Tripeptide boric acid (ester) compound and preparation method and application thereof |
07/17/2013 | CN101921330B Recombinant human interferon alpha 1b mutant and preparation method thereof |
07/17/2013 | CN101910182B Antitumor agent |
07/17/2013 | CN101861171B Polysaccharides grafted by polyamine for preparing radioactive pharmaceutical composition |
07/17/2013 | CN101824455B Soy protein oligopeptide, and preparation method and use thereof |
07/17/2013 | CN101821253B Piperidine derivative |
07/17/2013 | CN101626784B Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
07/17/2013 | CN101607936B Gimeracil crystal form and preparation method thereof |
07/17/2013 | CN101578279B Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors |
07/17/2013 | CN101573446B Aptamer against midkine and use thereof |
07/17/2013 | CN101502642B Use of hepatitis B virus x protein and encoding gene thereof in preparing medicament for treating cancer of liver |
07/17/2013 | CN101472943B SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
07/17/2013 | CN101412744B Anti-angiogenic compositions and methods of use thereof |
07/17/2013 | CN101222926B Methods and compositions for treating or preventing cancer |
07/17/2013 | CN101184506B Methods and compositions for modulating hyperstabilized c-met |
07/17/2013 | CN101160123B Combinations of therapeutic agents |
07/16/2013 | US8487096 Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors |
07/16/2013 | US8487090 Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof |
07/16/2013 | US8487003 Treatment of cancer by administration of perfluorooctanoic acid |
07/16/2013 | US8486955 Anti-cancer cyclopenta [g] quinazoline compounds |
07/16/2013 | US8486936 Antagonist of smoothened |
07/16/2013 | US8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
07/16/2013 | US8486895 Anti-epidermal growth factor receptor antibodies and uses thereof |
07/16/2013 | US8486698 Inducing differentiation of an isolated marrow stromal cell into a neuronal cell tissue engineering for use in prevention and treatment of nervous system disorders; regenerative medicine; tissue engineering |
07/16/2013 | US8486696 Cell populations which co-express CD49c and CD90 |
07/16/2013 | US8486455 Polymeric delivery formulations of leuprolide with improved efficacy |
07/16/2013 | US8486451 Adsorption and release of nitric oxide in metal organic frameworks |
07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
07/16/2013 | US8486404 Antibody specifically binding to angiopoietin-2 and use thereof |
07/16/2013 | US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF |